Evidence map›Paper›PMID 29866065›Full record

ArticleBMC cancer2018

Perceptions of and decision making about clinical trials in adolescent and young adults with Cancer: a qualitative analysis.

Jennifer A H Bell, Victoria Forcina, Laura Mitchell, Seline Tam, Kate Wang, Abha A Gupta, Jeremy Lewin

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. In their words: Experience of decision-making in adolescents with cancer - a qualitative meta-synthesis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jennifer A H BellJoint Center for Bioethics, University of Toronto, Toronto, Canada.
Victoria ForcinaAdolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada.
Laura MitchellAdolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada.
Seline TamAdolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada.
Kate WangAdolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada.
Abha A GuptaAdolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada. abha.gupta@sickkids.ca.
Jeremy LewinAdolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada.
Princess Margaret Cancer Centre · CAPeter MacCallum Cancer Centre · AUUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdolescent and young adults (AYA) enrolment rates into cancer clinical trials (CCT) are the lowest of any age group globally. As AYA have distinct biological, psychosocial and relational needs, we aimed to explore any unique factors influencing their CCT decision-making process, including AYA-specific perceptions or attitudes towards CCT.

methodsQualitative interpretive descriptive methodology was used to explore AYA perceptions and decision-making related to CCT. An analytic approach conducive to inductive imagining and exploratory questioning was used in order to generate insights and interpret data.

resultsA total of 21 AYA were interviewed (median age: 31 (18-39)). Twelve (57%) participants had previously been approached to participate in CCT. Major themes influencing trial enrolment decisions were: 1) severity of illness/urgency for new treatment 2) side effect profile of investigational drug in the short and long term (e.g., impact on future quality of life) 3) who approached patient for trial participation (oncologist vs. other) 4) additional information found on-line about the trial and investigators, and 5) family, friends and peer group opinion regarding the CCT.

conclusionsSeveral psychosocial and relational factors were identified as influencing AYA CCT decisions, some of which are unique to this demographic. Specific strategies to address barriers to CCT and enable supportive decision-making include: 1) involving family in decision-making and 2) helping AYA appreciate short- and long-term implications of trial participation. Finally, exploring social networking and general education about CCT that AYA can independently access may increase participation.

Indexed as

Clinical Trials as TopicHealth Knowledge, Attitudes, PracticeNeoplasmsPatient SelectionAdolescentAdultDecision MakingFemaleHumansMalePatient ParticipationYoung AdultAdolescent and young adultAttitudesBarriersBeliefsCancerClinical trialPerceptionPsychosocial

Identifiers

PMID29866065
PMCPMC5987432
OpenAlexW2806086535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.